- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06260215
Recovery Kinetics Following a Soccer Training in Middle-aged Males
February 19, 2024 updated by: Ioannis G. Fatouros, University of Thessaly
This study aims at investigating the recovery kinetics of skeletal muscle damage, neuromuscular fatigue and performance following a single soccer trainning session in middle aged males.
The participants will perform a soccer training session [A single training session including 60 minutes of warm up, soccer technical exercises and small-sided game] and a cotrol trial (No intervention included, only daily measurements) in randomized, repeated measures, crossover design.
Assesesments related to skeletal muscle damage, performance and neuromuscular fatigue will be executed before the training session and daily for four consecutive days after training.
Study Overview
Detailed Description
Eleven male middle-aged participants will be included in this study.
Participants will be initially informed about the main goals of study as well as the associated risks and benefits and then will provide their signed consent form.
At baseline, they will undergo assessment of their anthropometrics (body mass, height, BMI, WHR), body compotition (using DXA), physical contition level (peak oxygen consumption, VO2peak), haemodynamic profile (diastolic and diastolic blood pressure) and daily dietary intake.Thereafter, they will participate in two experimental trials (Control trial and Soccer trial) in a randomized, crossover, repeated measure design: 1) ST (Soccer Trial): Participants in this trial will perform a soccer training session (60 min) consisted of warm-up, technical exercises and small-sided game, CT (Control Trial): Participants in this trial will only execute the evaluations daily in the dependent variables (they will not receive any intervention).
Before each trial, the participants will provide a resting blood sample (for the determination of white blood cells, granulocyte cells, monocyte cells, lymphocyte cells, Hemeatocrit, Hemoglobin, red blood cells and platelets, total antioxidant capacity, glutathione and creatine kinase activity) and undergo assessments of their delay onset muscle soreness (DOMS), maximal voluntary isometric contraction (MVIC) of knee extensors and flexors (by isokinetic dynamometer), height and power of countermovement jump (CMJ-using force platform), 10m and 30m sprint time (will be evaluated using light cells).
A 7-day wash-out period will apllied between ST and CT.
The blood sample will be collected before and 24, 48 and 72 hours post-taining.
Also, the evaluation of DOMS, MVIC, sprinting performance, power and jump height (by CMJ) will be evaluated before and 24, 48, 72 and 96 hours post training.
Study Type
Interventional
Enrollment (Estimated)
11
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ioannis G Fatouros, Prof
- Phone Number: +30 24310 47047
- Email: ifatouros@.pe.uth.gr
Study Contact Backup
- Name: Athanasios Z Jamurtas, Prof
- Phone Number: +30 24310 47054
- Email: ajamurt@pe.uth.gr
Study Locations
-
-
-
Tríkala, Greece, 42100
- Recruiting
- University o Thessaly, School of Physical Education and Sports Science
-
Principal Investigator:
- Athanasios S Poulios, PhD
-
Contact:
- Athanasios Z Jamurtas, Prof
- Phone Number: +30 24310 47054
- Email: ajamurt@pe.uth.gr
-
Contact:
- Ioannis G Fatouros, Prof
- Phone Number: +30 24310 47047
- Email: ifatouros@pe.uth.gr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Free of musculoskeletal injuries
- No use of ergogenic supplements or medication
- Free of chronic diseases
- age of 40-60 years
Exclusion Criteria:
- Musculoskeletal injury
- Use of alcohol, caffeine and any type of ergogenic supplements or medication during the course of the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
Participants in this arm will receive no intervention
|
|
Experimental: ST
Participants in this arm will participate in a soccer training (ST) session for 60 minutes.
During the training the participans will execute the warm-up process, the part of soccer technical exercises and they will play a small-side-game.
|
Participants will perform a soccer training (ST) session for 60 minutes.
The training will include the warm-up, soccer technical exercises and a small-side game
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in White blood cell count
Time Frame: At baseline, at 24, 48 and 72 hours after soccer training
|
White blood cell count will be measured using an automatic blood analyzer
|
At baseline, at 24, 48 and 72 hours after soccer training
|
Change in Granulocyte cell count
Time Frame: At baseline, at 24, 48 and 72 hours after soccer training
|
Change in White blood cell count will be measured using an automatic blood analyzer
|
At baseline, at 24, 48 and 72 hours after soccer training
|
Change in Platelets cell count
Time Frame: At baseline, at 24, 48 and 72 hours after soccer training
|
Platelets cell count will be measured using an automatic blood analyzer
|
At baseline, at 24, 48 and 72 hours after soccer training
|
Change in Monocyte cell count
Time Frame: At baseline, at 24, 48 and 72 hours after soccer training
|
Monocytes cell count will be measured using an automatic blood analyzer
|
At baseline, at 24, 48 and 72 hours after soccer training
|
Change in Lymphocyte cell count
Time Frame: At baseline, at 24, 48 and 72 hours after soccer training
|
Lymphocyte cell count will be measured using an automatic blood analyzer
|
At baseline, at 24, 48 and 72 hours after soccer training
|
Change in percentage of Hematocrit level
Time Frame: At baseline, at 24, 48 and 72 hours after soccer training
|
The percentage of Hematocrit level will be measured using an automatic blood analyzer
|
At baseline, at 24, 48 and 72 hours after soccer training
|
Change Red blood cells count
Time Frame: At baseline, at 24, 48 and 72 hours after soccer training
|
Red blood cells count will be measured using an automatic blood analyzer
|
At baseline, at 24, 48 and 72 hours after soccer training
|
Change in Hemoglobin level
Time Frame: At baseline, at 24, 48 and 72 hours after soccer training
|
Hemoglobin level will be measured using an automatic blood analyzer
|
At baseline, at 24, 48 and 72 hours after soccer training
|
Change in Creatine kinase activity
Time Frame: At baseline, at 24, 48 and 72 hours after soccer training
|
Creatine kinase activity will be measured in plasma
|
At baseline, at 24, 48 and 72 hours after soccer training
|
Change in Total antioxidant capacity
Time Frame: At baseline, at 24, 48 and 72 hours after soccer training
|
Total antioxidant capacity will be measured in plasma
|
At baseline, at 24, 48 and 72 hours after soccer training
|
Change in Glutathione concentration in blood
Time Frame: At baseline, at 24, 48 and 72 hours after soccer training
|
Glutathione concentration will be measured in red blood cells
|
At baseline, at 24, 48 and 72 hours after soccer training
|
Change in countermovement jump height
Time Frame: At baseline, at 24, 48, 72 and 96 hours after soccer training
|
countermovement jump height will be measured using a force platform
|
At baseline, at 24, 48, 72 and 96 hours after soccer training
|
Change in Peak power during coutermovement jump test
Time Frame: At baseline, at 24, 48, 72 and 96 hours after soccer training
|
The peak power will be measured using a force platform
|
At baseline, at 24, 48, 72 and 96 hours after soccer training
|
Change in isometric peak torque of knee extensors and flexors
Time Frame: At baseline, at 24, 48, 72 and 96 hours after soccer training
|
Isometric peak torque will be assessed on an isokinetic dynamometer
|
At baseline, at 24, 48, 72 and 96 hours after soccer training
|
Change in sprint time of 10 m
Time Frame: At baseline, at 24, 48, 72 and 96 hours after soccer training
|
10m sprint time will be assessed using light cells
|
At baseline, at 24, 48, 72 and 96 hours after soccer training
|
Change in sprint time of 30 m
Time Frame: At baseline, at 24, 48, 72 and 96 hours after soccer training
|
30m sprint time will be assessed using light cells
|
At baseline, at 24, 48, 72 and 96 hours after soccer training
|
Change in delayed onset of muscle soreness
Time Frame: At baseline, at 24, 48, 72 and 96 hours after soccer training
|
Muscle soreness will be assessed by palpation of muscle belly and the distal region
|
At baseline, at 24, 48, 72 and 96 hours after soccer training
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lean body mass
Time Frame: At baseline
|
Lean body mass will be measured by using Dual-emission X-ray absorptiometry
|
At baseline
|
Dietary intake
Time Frame: At baseline
|
Dietary intake will be assesed over a 7-day period using diet recalls
|
At baseline
|
Peak Maximal oxygen consumption (Peak VO2)
Time Frame: At baseline
|
Peak VO2 will be estimated by open circuit spirometry via breath by breath method
|
At baseline
|
Body Mass
Time Frame: At baseline
|
Body Mass will be measured on a beam balance with stadiometer
|
At baseline
|
Body Height
Time Frame: At baseline
|
Body Height will be measured on a beam balance with stadiometer
|
At baseline
|
Body Fat
Time Frame: At baseline
|
Body Fat will be measured by using Dual-emission X-ray absorptiometry
|
At baseline
|
Bone mass density
Time Frame: At baseline
|
Bone mass density will be measured by using Dual-emission X-ray absorptiometry
|
At baseline
|
Bone mass content
Time Frame: At baseline
|
Bone mass content will be measured by using Dual-emission X-ray absorptiometry
|
At baseline
|
Field activity during the soccer training
Time Frame: During the 60 minutes soccer training (ST) session (72 hours after baseline measurements)
|
The field activity will be continuously monitored during the soccer training using global positioning system (GPS)
|
During the 60 minutes soccer training (ST) session (72 hours after baseline measurements)
|
Heart rate during the soccer training
Time Frame: During the 60 minutes soccer training (ST) session (72 hours after baseline measurements)
|
Heart rate will be continuously monitored during the soccer training using heart rate monitors
|
During the 60 minutes soccer training (ST) session (72 hours after baseline measurements)
|
Systolic Blood Pressure
Time Frame: At baseline
|
Systolic Blood Pressure will be examined using sphygmomanometer
|
At baseline
|
Dystolic Blood Pressure
Time Frame: At baseline
|
Dystolic Blood Pressure will be examined using sphygmomanometer
|
At baseline
|
Rest Heart Rate
Time Frame: At baseline
|
The rest heart rate will be estimated using a heart rate monitor
|
At baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Ioannis G Fatouros, Prof, University of Thessaly
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 5, 2024
Primary Completion (Estimated)
February 26, 2024
Study Completion (Estimated)
March 9, 2024
Study Registration Dates
First Submitted
January 29, 2024
First Submitted That Met QC Criteria
February 6, 2024
First Posted (Actual)
February 15, 2024
Study Record Updates
Last Update Posted (Estimated)
February 21, 2024
Last Update Submitted That Met QC Criteria
February 19, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- FFH
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skeletal Muscle Damage
-
University of ThessalyCompletedAthletic Performance | Muscle Damage | Skeletal Muscle DamageGreece
-
University of ThessalyCompleted
-
Democritus University of ThraceCompletedSkeletal Muscle Performance | Skeletal Muscle Damage | Intgracellular Signaling in Skeletal Muscle | Inflammatory StatusGreece
-
National and Kapodistrian University of AthensCompletedSkeletal Muscle Damage | Aseptic Inflammation | Skeletal Muscle FunctionGreece
-
University of ThessalyCompletedSkeletal Muscle Performance | Skeletal Muscle Damage | Exercise-induced Aseptic Inflammation | Intracellular Signaling in Skeletal Muscle | Proteasome ActivationGreece
-
University of ThessalyCompletedSkeletal Muscle Performance | Skeletal Muscle Damage | Exercise-induced Aseptic Inflammation | Antioxidant StatusGreece
-
University of ThessalyCompletedMuscle Inflammation | Skeletal Muscle Damage | Soccer Performance | Muscle RecoveryGreece
-
University of ThessalyCompletedPerformance | Skeletal Muscle Damage | Exercise-induced Aseptic InflammationGreece
-
AdventHealth Translational Research InstituteActive, not recruiting
Clinical Trials on ST
-
Nanyang Technological UniversityActive, not recruitingPhysiological Outcomes of High-intensity Interval Training With Post-exercise Blood Flow RestrictionExercise PerformanceSingapore
-
Abbott Medical DevicesTerminatedCoronary Artery DiseaseUnited States
-
Istituto Superiore di Osteopatia di MilanoCompletedHealthy | Osteopathic ManipulationItaly
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)RecruitingPeripheral NeuropathyUnited States
-
University Hospitals Coventry and Warwickshire...RecruitingNervous System Diseases | Neuromuscular Diseases | Respiratory Failure | Respiratory Insufficiency | Amyotrophic Lateral Sclerosis | Sleep-Disordered Breathing | Neuro-Degenerative Disease | Neuron Disease, MotorUnited Kingdom
-
SIGA TechnologiesNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Sangamo TherapeuticsEnrolling by invitationFabry Disease | Fabry Disease, Cardiac VariantUnited States, Australia, United Kingdom
-
Thomas Jefferson UniversityJohns Hopkins University; Dartmouth-Hitchcock Medical CenterCompletedAge-Related Macular DegenerationUnited States
-
SIGA TechnologiesNational Institutes of Health (NIH)CompletedOrthopoxviral DiseaseUnited States
-
Abbott Medical DevicesCompleted